We are live on ! Find out more
BIIB icon

Biogen
BIIB

1,014 hedge funds and large institutions have $59B invested in Biogen in 2017 Q3 according to their latest regulatory filings, with 99 funds opening new positions, 380 increasing their positions, 356 reducing their positions, and 68 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more funds holding in top 10

Funds holding in top 10: 23 → 38 (+15)

46% more first-time investments, than exits

New positions opened: 99 | Existing positions closed: 68

16% more capital invested

Capital invested by funds: $50.9B → $59B (+$8.14B)

2% more funds holding

Funds holding: 992 → 1,014 (+22)

1.38% more ownership

Funds ownership: 87.77% → 89.15% (+1.4%)

7% more repeat investments, than reductions

Existing positions increased: 380 | Existing positions reduced: 356

22% less call options, than puts

Call options by funds: $974M | Put options by funds: $1.24B

Holders
1,014
Holders Change
+22
Holders Change %
+2.22%
% of All Funds
25.28%
Holding in Top 10
38
Holding in Top 10 Change
+15
Holding in Top 10 Change %
+65.22%
% of All Funds
0.95%
New
99
Increased
380
Reduced
356
Closed
68
Calls
$974M
Puts
$1.24B
Net Calls
-$269M
Net Calls Change
-$87M

Top Buyers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$513M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$310M
3
Ameriprise
Ameriprise
Minnesota
+$178M
4
AQR Capital Management
AQR Capital Management
Connecticut
+$167M
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$133M

Top Sellers

1
BlackRock
BlackRock
New York
-$344M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$206M
3
Renaissance Technologies
Renaissance Technologies
New York
-$190M
4
SIG
Senator Investment Group
New York
-$136M
5
Citadel Advisors
Citadel Advisors
Florida
-$119M
Name Holding Trade Value Shares
Change 		Change in
Stake
TYCC
576
Texas Yale Capital Corp
Florida
$1.25M – – –
MWM
577
Marietta Wealth Management
Georgia
$1.25M +$1.18M +3,984 New
GXMC
578
Global X Management Company
New York
$1.23M +$86.2K +291 +8%
RWA
579
Ropes Wealth Advisors
Massachusetts
$1.23M – – –
FNBT
580
FineMark National Bank & Trust
Florida
$1.23M +$246K +830 +27%
QT
581
Quantbot Technologies
New York
$1.22M +$1.1M +3,699 +1,761%
IH
582
IFC Holdings
Florida
$1.22M +$1.15M +3,890 New
EF
583
Empirical Finance
Pennsylvania
$1.2M – – –
WIS
584
Wright Investors Service
Connecticut
$1.2M +$426K +1,439 +61%
AI
585
Atria Investments
North Carolina
$1.19M +$267K +900 +31%
NEI
586
Northwest & Ethical Investments
Ontario, Canada
$1.19M +$1.06M +3,563 +1,503%
MML Investors Services
587
MML Investors Services
Massachusetts
$1.18M -$1.78K -6 -0.2%
ZCA
588
Zeke Capital Advisors
Pennsylvania
$1.18M +$693K +2,340 +164%
ACP
589
Aviance Capital Partners
Florida
$1.18M -$185K -625 -14%
LCS
590
Levin Capital Strategies
New York
$1.17M – – –
Federated Hermes
591
Federated Hermes
Pennsylvania
$1.16M -$267K -902 -20%
DVM
592
Dreman Value Management
Florida
$1.16M – – –
BAM
593
Belpointe Asset Management
Nevada
$1.15M +$1.09M +3,686 New
MSR
594
Main Street Research
Connecticut
$1.11M -$104K -352 -9%
FLPIM
595
F.L. Putnam Investment Management
Massachusetts
$1.1M +$1.04M +3,522 New
WS
596
Wedbush Securities
California
$1.09M +$296 +1 +0%
CCM
597
CrestPoint Capital Management
Missouri
$1.06M -$148K -500 -13%
PI
598
PineBridge Investments
New York
$1.06M +$886K +2,991 +785%
AP
599
Appleton Partners
Massachusetts
$1.05M -$697K -2,355 -41%
IA
600
IFP Advisors
Florida
$1.04M +$316K +1,066 +47%
22 23
24
25 26

BIIB Hedge Fund Activity: Q3 2017 in Review

1,014 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Biogen (BIIB) for Q3 2017, worth a combined $59B — up 16% from $50.9B a quarter earlier.

Buyers outnumbered sellers: 99 funds opened new BIIB positions and 68 closed out — a net gain of 31 holders — while 380 added to existing stakes and 356 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $513M. The largest seller was BlackRock, cutting an estimated $344M.

  • 1,014 institutional investors held Biogen (BIIB) as of Q3 2017, up from 992 in Q2 2017.
  • Funds reported $59B of Biogen stock for Q3 2017, up 16% quarter-over-quarter.
  • 99 funds opened new Biogen positions in Q3 2017 and 68 closed out, a net change of +31 holders.
  • The largest Biogen buyer in Q3 2017 was T. Rowe Price Associates, an estimated $513M added.
  • The largest Biogen seller in Q3 2017 was BlackRock, an estimated $344M sold.

Based on aggregated 13F filings for Q3 2017.